Embic’s digital cognitive biomarkers are used in various drug development, academic research, clinical care, and other commercial settings. With a flexible delivery platform using SaaS or private XML access, Embic enables quick and reliable cognitive assessment and data scoring capabilities to our research partners and healthcare customers .
Embic provides various data analyses and consulting services upon request. These services include deriving digital cognitive biomarkers from existing neuropsychological data (e.g., CERAD, ADAS-Cog, and other data) with sophisticated algorithms to reduce noise and discern subtle treatment effects. Our analytical services also include customized analyses that utilize our proprietary clinical database of normative values to help answer specific questions about treatment effects across carefully specified populations.
Embic’s proprietary database contains extensive information that is used in our ongoing research & development efforts. These de-identified and aggregated data include risk factors, diagnoses, longitudinal memory performance scores, medications, and rate of progression for patients across a variety of demographic profiles. Analyzing this data can identify various correlations, patterns, and treatment effects that might open new insights into the mechanisms and treatments for neurodegenerative diseases like Alzheimer’s disease (AD).
Embic’s expert team is available to explore any collaborative opportunities you may envision. Please contact us at firstname.lastname@example.org to explore your ideas.